Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,719 | 149,991 | 92,865 | 101,910 | 120,754 |
| Marketable Securities | 320,933 | 348,517 | 319,504 | 357,997 | 192,810 |
| TOTAL | $451,672 | $502,314 | $419,809 | $466,550 | $321,205 |
| Non-Current Assets | |||||
| PPE Net | 6,403 | 6,149 | 6,400 | 5,396 | 4,537 |
| Investments And Advances | 0 | 0 | 0 | 22,277 | 217,578 |
| Other Non-Current Assets | 4,492 | 4,705 | 30 | 2,530 | 5,030 |
| TOTAL | $10,895 | $10,854 | $6,430 | $30,203 | $227,145 |
| Total Assets | $462,567 | $513,168 | $426,239 | $496,753 | $548,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,722 | 15,316 | 8,945 | 16,231 | 15,735 |
| Accrued Expenses | 41,826 | 42,687 | 19,217 | 12,828 | 13,720 |
| TOTAL | $50,529 | $60,260 | $28,236 | $30,416 | $29,537 |
| Non-Current Liabilities | |||||
| Long Term Debt | 188,323 | 185,146 | 182,104 | 179,038 | 176,052 |
| Deferred Revenues | N/A | N/A | 74 | 78 | 82 |
| Other Non-Current Liabilities | 6,864 | 6,954 | 1,658 | 1,658 | 1,505 |
| TOTAL | $195,187 | $192,100 | $184,272 | $181,210 | $178,052 |
| Total Liabilities | $245,716 | $252,360 | $212,508 | $211,626 | $207,589 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,637 | 83,504 | 68,500 | 68,327 | 68,236 |
| Common Shares | 8 | 8 | 7 | 7 | 7 |
| Retained earnings | -1,140,283 | -1,081,872 | -963,938 | -883,849 | -822,929 |
| Other shareholders' equity | 106,497 | 103,261 | 102,699 | 99,577 | 99,740 |
| TOTAL | $216,851 | $260,808 | $213,731 | $285,127 | $340,761 |
| Total Liabilities And Equity | $462,567 | $513,168 | $426,239 | $496,753 | $548,350 |